Your browser doesn't support javascript.
loading
Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge.
Krolik, Michal; Csepregi, Lucia; Hartmann, Fabienne; Engetschwiler, Céline; Flatz, Lukas.
Afiliação
  • Krolik M; Institute of Immunobiology, Kantonsspital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland.
  • Csepregi L; Institute of Immunobiology, Kantonsspital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland.
  • Hartmann F; Institute of Immunobiology, Kantonsspital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland.
  • Engetschwiler C; Institute of Immunobiology, Kantonsspital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland.
  • Flatz L; Institute of Immunobiology, Kantonsspital St.Gallen, Rorschacher Strasse 95, 9007 St.Gallen, Switzerland; Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland; Department of Oncology and Hematology, Kantonsspital St.Gallen, Rorschacher Strasse 95, 9007 St
Vaccine ; 39(8): 1257-1264, 2021 02 22.
Article em En | MEDLINE | ID: mdl-33518468

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Receptor de Interferon alfa e beta / Vírus da Coriomeningite Linfocítica Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Receptor de Interferon alfa e beta / Vírus da Coriomeningite Linfocítica Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article